Thinking about trading options or stock in Tesla, Energy Transfer, Paramount Global, Vertex Pharmaceuticals, or Broadcom ?
Thinking about trading options or stock in Tesla, Energy Transfer, Paramount Global, Vertex Pharmaceuticals, or Broadcom ?
PR Newswire
NEW YORK, March 21, 2024
NEW YORK, March 21, 2024 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for TSLA, ET, PARA, VRTX, and AVGO.
Click a link below then choose between in-depth options trade idea report or a stock score report.
Options Report – Ideal trade ideas on up to seven different options trading strategies. The report shows all vital aspects of each option trade idea for each stock.
Stock Report - Measures a stock's suitability for investment with a proprietary scoring system combining short and long-term technical factors with Wall Street's opinion including a 12-month price forecast.
- TSLA: https://www.investorsobserver.com/lp/pr-options-lp-2/?stocksymbol=TSLA&prnumber=202403211
- ET: https://www.investorsobserver.com/lp/pr-options-lp-2/?stocksymbol=ET&prnumber=202403211
- PARA: https://www.investorsobserver.com/lp/pr-options-lp-2/?stocksymbol=PARA&prnumber=202403211
- VRTX: https://www.investorsobserver.com/lp/pr-options-lp-2/?stocksymbol=VRTX&prnumber=202403211
- AVGO: https://www.investorsobserver.com/lp/pr-options-lp-2/?stocksymbol=AVGO&prnumber=202403211
(Note: You may have to copy this link into your browser then press the [ENTER] key.)
InvestorsObserver provides patented technology to some of the biggest names on Wall Street and creates world-class investing tools for the self-directed investor on Main Street. We have a wide range of tools to help investors make smarter decisions when investing in stocks or options.
View original content to download multimedia:https://www.prnewswire.com/news-releases/thinking-about-trading-options-or-stock-in-tesla-energy-transfer-paramount-global-vertex-pharmaceuticals-or-broadcom--302095893.html
SOURCE InvestorsObserver
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
Markets Brief: Stocks Are Starting to Look Cheap Again
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast
-
Alphabet Shares Surge on Strong Earnings, Dividend Surprise
-
Microsoft Earnings: Firm Beats Forecasts on Strong AI and Cloud Demand
-
PG&E Earnings: Near-Term Regulatory Certainty Supports Industry-Leading Earnings Growth